About this trial
Rationale: Self-report measures are frequently used for research and clinical assessments of adults with autism spectrum disorder (ASD). However, there has been little research examining agreement between self-report and informant-report in this population. Reliable self-report measures are essential for conducting research with and providing high quality clinical services for adults with autism spectrum disorder.
Objective: This study aims to examine the usefulness of self-report of DSM-5-TR PD traits in adults with ASD compared to informant-reports by administering the self-report screening measure of the Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Adult males and females (age ≥ 18 years), clinically diagnosed with ASD by a psychologist or a psychiatrist, without intellectual disability, and their informants. ASD participants will be recruited from Sarr Autism Rotterdam, the Netherlands, specialized in psychodiagnostic assessment and treatment for children, adolescents, and adults with ASD. Sarr is part of Parnassia Groep, multisite mental health institute in the Netherlands.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Structured Clinical Interview for DSM-5 Screening Personality Questionnaire (SCID-5-SPQ).
Other interventionScreening questionnaire
Treatment groups
Trial outcomes
Primary outcomes
Score SCID-5-PD
The main study parameters are the item scores on the Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD). The participant can score with Yes and No on the questions. The scoring parameters are 0 (No) and 1 (Yes). This is for all items. A higher score means that the participant scores on that personality item.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.